New Version of IMPACT CTMS in Market - Analyst Blog

By
A A A

Recently, a subsidiary of PAREXEL International Corp ( PRXL ), Perceptive Informatics, introduced an upgraded version of its IMPACT clinical trial management system (CTMS). IMPACT CTMS solution reports, plans and tracks clinical trials, for its clients which includes many pharmaceutical and biotechnology companies.

According to Perceptive Informatics, the enhanced features of this new system, including improved data entry as well as site management and monitoring capabilities, will help customers keep up with rapid evolution in technology used in clinical trials.

Overall, the upgraded version of IMPACT CTMS solution will be more flexible as well as improve the speed and effectiveness of their clinical development programs. Perceptive's enhanced version is a customizable system that allows managers the choice of selecting the most suitable information for clinical use and then configures it consequently. This system has over 26,000 users who can study thousands of subjects and has millions of visitors.


Currently, Parexel carries a Zacks Rank #3 (Hold). This leading biopharmaceutical services company provides clinical research, consultation, and commercialization as well as technology products to various industries such as pharmaceutical, biotechnology and medical devices.

Based in Waltham, MA, the company operates in three major segments - clinical research services, Parexel consulting and medical communications services and perceptive informatics. PAREXEL operates in 73 locations throughout 51 countries around the world.

Other medical product stocks worth considering are Air Methods Corp. ( AIRM ), ICON Public Ltd ( ICLR ) and Catamaran Corp ( CTRX ). While Air Methods Corp. carries a Zacks Rank #1 (Strong Buy), ICON Public Limited and Catamaran Corporation carry a Zacks Rank #2 (Buy).



AIR METHODS CRP (AIRM): Free Stock Analysis Report

CATAMARAN CORP (CTRX): Free Stock Analysis Report

ICON PLC (ICLR): Free Stock Analysis Report

PAREXEL INTL CP (PRXL): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: AIRM , CTRX , ICLR , PRXL

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

33,974,386
  • $17.98 ▲ 0.28%
20,763,901
  • $91.29 ▲ 2.06%
19,110,793
  • $7.26 ▼ 1.22%
18,528,869
    $8.33 unch
18,014,920
  • $4.19 ▼ 1.18%
16,448,919
  • $25.83 ▼ 0.19%
14,748,190
  • $7.60 ▼ 1.43%
14,144,383
  • $112.01 ▼ 0.47%
As of 12/24/2014, 02:12 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com